Manila Times Business
TechForce Robotics Enters Pharmaceutical Automation Market Through Initial Deployment at Oncotelic Therapeutics
Deployment of the Company's LIM-E autonomous laboratory support robot completes Phase 1 objectives under the joint development agreement and establishes a foundation for future pharmaceutical automation initiatives LOS ANGELES, June 01, 2026 (GLOBE NEWSWIRE) -- via IBN - TechForce Robotics, Inc. ("TechForce"), a subsidiary of Nightfood Holdings, Inc. (OTCQB: NGTF), today announced the successful completion of Phase 1 objectives under its joint development agreement with Oncotelic Therapeutics, I
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Bonoan rushed to hospital over ‘near stroke’ — Remulla
Just now
BriaCell Presents Positive Clinical Data at ASCO 2026
Just now
Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York
Just now
Brixton Metals Drills 2.3 m of 1,811 g/t Silver within 27.7 m of 166.45 g/t Silver at its Langis Project
Just now